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Abstract
Caveolae appear in a multitude of processes encompassing growth regulation and trafficking. We demonstrate the
abundant presence of ESA/reggie-1/flotillin-2, ATP synthase β subunit and annexin V in endothelial caveolae by
immunopurification of caveolae from vascular endothelial membrane. Five proteins are abundant in a caveolin-
1 protein complex, analyzed by sucrose gradient velocity sedimentation following octyl-β-D-glucopyranoside
extraction. Caveolin-1 α interacts with caveolin-1 β, caveolin-2, actin, the microsomal form of NADH cytochrome
B5 reductase and ESA/reggie-1/flotillin-2 as shown by co-immunoprecipitation. We propose the concept that ATP
biosynthesis in caveolae regulates mechanosignaling and is induced by membrane depolarization and a proton
gradient. Pressure stimuli and metabolic changes may trigger gene regulation in endothelial cells, involving a
nuclear conformer of caveolin-1, shown here with an epitope-specific caveolin-1 antibody, and immediate response
of ion channel activity, regulated by ESA/reggie-1/flotillin-2.
Introduction
Blood vessels constrict upon innervation and autonom-
ously in orthostatic changes, which increase the hydro-
static pressure in the vascular system [1] (but see [2]).
The heartbeat regulates systemic blood flow by ad-
justing the frequency and output and constriction of
vessels contributes to local regulation. Nitric oxide
(NO) is tonically produced in caveolae by endothelial
NO synthase (eNOS) to balance vessel tonus and
dilates the vessels [3, 4]. Caveolae have been implic-
ated in general mechanotransduction upon shear flow,
are increased in number upon laminar shear exposure
and are relocated during migration in living cells [5–
8]. Caveolae from endothelia have been studied by
western blotting of immunoisolated membranes. They
were shown to contain thrombomodulin, functional
thrombin receptor, G protein αq and endothelial nitric
oxide synthase [9–11]. The stoichiometry of proteins,
however, interacting with caveolin and composition
of endothelial caveolae, as distinct from lipid rafts in
general [12], has not yet been determined.
The process of mechanotransduction is likely con-
nected to compliance modulation and it is indicative,
that vascular abnormalities are found in caveolin-1
null mice [13, 14]. The recent immunopurification of
caveolae from adipocytes, however, shows that SSAO,
an extracellular amine oxidase that might modulate
lipolysis, and CD36, a scavenger receptor, are ma-
jor components [15]. In addition it has been found,
that cardiac caveolae contain a significant fraction of
Na+/K+-ATPase implicated in maintaining a mem-
brane potential [16]. It is suggested to stimulate ex-
change of calcium by the Na+/Ca2+-exchanger, pre-
viously shown to associate with caveolin-3 and to be
involved in regulation of endothelial nitric-oxide syn-
thase [17, 18]. If this composition were generally
found for caveolae of all types of cells, one could
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Figure 1. Caveolae immunoisolation. All experiments in panels a–h were carried out with membranes isolated from rat lung endothelia by
colloidal silica perfusion. (a) Electron microscopy of P1 membranes. Luminal endothelial plasma membrane adheres to the silica particles
(average size 50 nm), caveolae are visible as protruding structures. Bar 50 nm. (b) Protein composition of endothelial plasma membrane. The
lung homogenate (LH, 100 µg, lane 1) and P2 membranes (PM P2, 75 µg, lane 2) obtained by the silica perfusion method were analyzed
by 14% SDS-PAGE and Coomassie blue staining of gels. The identity of caveolin-1 was confirmed by western blotting with caveolin-1
polyclonal antibodies (not shown). Molecular weight markers are indicated. (c) Protein composition of endothelial plasma membrane. 100 µg
of P1 membranes were resolved on two-dimensional gels by isoelectric focussing. The sample was solubilized in loading buffer and the
supernatant (in the absence of silica beads) was resolved on non-linear 3.5–10 immobilized pH gradient (IPG) focussing strips. Proteins
were visualized by silver-staining. (d) Specificity of the cav1N14 antibody. 7.5 µg of P1 membranes were resolved by 12% SDS-PAGE
and incubated with affinity-purified cav1N14 antibodies in the absence (lane 1) or presence (lane 2) of excess of the antigen. The blot was
developed by enhanced chemiluminescence. (e) Subcellular fractionation. For immunoisolation P1 membranes were sonicated, adjusted to
1.7 M sucrose and fractionated on a 0.25 M / 1.09 M two-step sucrose flotation gradient. A sample of the gradient fractions was resolved by 14%
SDS-PAGE, caveolin-1 α and β was visualized by western blotting with caveolin-1 polyclonal antibodies and enhanced chemiluminescence.
(f) Immunoisolation. 40 µg of caveolin-enriched membranes (derived from pooled fractions 2–4; panel e) were incubated with immunobeads
pre-adsorbed with (lane 1) or without (lane 2) affinity-purified cav1N14 antibodies. Bound (lanes 1, 2) and unbound membranes (lanes 3, 4)
were analyzed by 14% SDS-PAGE. 2 µg of the starting material (SM) is shown in lane 5. Nitrocellulose blots were developed by enhanced
chemiluminescence and quantified by densitometry. (g)–(h) Immunoisolation from an independent experiment. Equal amounts of light mem-
branes corresponding to fractions 2–4 (panel e) were incubated with (lanes 3) or without (lanes 4) affinity-purified cav1N14 antibodies and
retrieved with immunobeads. The antibody alone (6 µg) was incubated as control (lanes 2). Samples were resolved by 14% SDS-PAGE. 1/10
of the starting material (SM) is shown in lanes 1. The nitrocellulose blot (panel h) was incubated with the ESA/reggie-1/flotillin-2 monoclonal
and caveolin-1 polyclonal antibody and developed by enhanced chemiluminescence. The nitrocellulose blot stained with Ponceau S is shown
in panel h. ESA/reggie-1/flotillin-2, caveolin-1 α and β and molecular weight markers are indicated. (i)–(l) Localization of caveolin-1 and
ESA/reggie-1/flotillin-2 in calf pulmonary artery endothelial (CPAE) cells. Cells were viewed and photographed with a confocal microsocope.
Caveolin-1 α was visualized with caveolin-1 antibodies and secondary fluorescein conjugated antibodies (i, k). ESA/reggie-1/flotillin-2 was
simultaneously detected with monoclonal ESA/reggie-1/flotillin-2 antibodies and secondary Cy3 antibodies (j, l). Singly labeled spots are
indicated with →, double labeled areas and spots are indicated with ⇒. Picture sizes: 100 × 100 µm top row, zoom 25 × 25 µm bottom row.
surmise that caveolae are involved in integration of
ion fluxes [19] that, similar to synaptic vesicle release,
leads to a physiological response.
Along another line, caveolae are proposed to be
trafficking organelles, but the function of caveolin-1
and -2 in vesicular transport is controversial and the
proteins have been suggested to be internalized sel-
dom, similar to junctional factors [20–22]. Caveolae
can be exploited in pathogen uptake [23], and although
this organelle might show a remarkable plasticity,
evident e.g. for related caveolin-3 in muscle [24], the
most coherent explanation is that the dynamics of the
cell contributes to many roles.
Mechanotransduction triggers intracellular signal-
ing [25, 26]. The lipid bilayer is stabilized by cyto-
skeletal attachment and receives shear forces and pres-
sure stimuli. In vitro results suggest that pressure
is integrated in bilayer mechanics and ion channel
conductance. Membranes depolarize upon deforma-
tion from their resting potential by ion fluxes. The
ion channel activity is affected by various interac-
tions ranging from protein-protein, ionic to oxygen
and enzymatic modification. Ion channels are pro-
posed to link the extracellular matrix and the cyto-
skeleton and deflection of shear force triggers channel
response [27–31]. At the same time, bilayer fluid-
ity is altered in effective mechanosignaling [32] (see
also [33]). Pressure regulates cell growth, impacts on
the transcriptional repertoire [25], and affects chro-
matin structure (shear stress) [34].
The modularity which pertains to membrane sig-
naling and organization also prevails for the location
of biochemical reactions previously thought to be re-
stricted to the mitochondrium. ATP biosynthesis in
the exoplasm is a new phenomenon of unknown role
shown in endothelia [35]. It involves mitochondrial
ATP synthase encoded in the nuclear genome as open
reading frames or as pseudogenes [36, 37], which
may be expressed [38, 39]; the enzyme is alternatively
targeted to the plasma membrane [35, 40, 41]. Extra-
cellular ATP is a ligand for purinergic receptors [42],
kinases and possibly other enzymes [43] and generally
is found extracellular upon mechanical stimulation of
cells [42, 44]. Although in this role, ATP release from
endothelia upon shear stress was suggested to occur
by a vesicular mechanism [45] and chromaffin granule
import of ions and ATP for neurosecretion has been
demonstrated [46], the question remains how extracel-
lular ATP generally is set free. This might relate to the
integration functions of caveolae in signaling, and not
to ion homeostasis, as previously proposed [47].
We now show that the composition of caveolae is
simple with ESA/reggie-1/flotillin-2, previously ana-
lyzed [48–51], as one of the major components in
addition to ATP synthase and annexin V. ESA/reggie-
1/flotillin-2 homologues are implicated in ion chan-
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nel regulation and provide DEG channel coactiv-
ity [26, 52]. Caveolae may thus fulfil functions in




Plasma membranes, isolated from rat lungs, were
visualized by electron microscopy and showed silica
particles with protrusions of membrane and cave-
olae (Figure 1a). These membranes were previously
labeled with caveolin-1 antibodies demonstrating the
abundance and presence of caveolae [9]. In lung ho-
mogenate caveolin-1 was enriched in the plasma mem-
brane preparation (Figure 1b) as visualized by SDS-
PAGE (and western overlay). To analyze the complex-
ity of the protein composition, the membrane isolate
was resolved by two-dimensional (2D) immobilized
pH gradient (IPG) SDS-PAGE. One major silver-
stained spot (Figure 1c) corresponded to β/γ actin,
the other proteins could not be compared directly to
standard 2D-IPG-SDS-PAGE databases. The further
analysis resulted in the identification of a 50 kDa pro-
tein as a substoichiometric but second most abundant
protein of the caveolae preparation. To the aim of
biochemical analysis, antibodies were raised against
the cav1N14 peptide and specificity was demonstrated
by western blotting (Figure 1d). Membranes were
released from the silica particles by sonication to har-
vest a light membrane fraction. Beads were overlaid
with sucrose solution and centrifuged to float light
membranes (Figure 1e). The majority of caveolin-1
containing membranes was present in fractions 2–4
of the gradient corresponding to a sucrose density of
less than 1.14 g/cm3. These light membranes were
used for all subsequent experimental procedures. It
is of note, that the light membranes (fractions 2–4)
corresponded to only 0.03% of total lung homogenate
protein (filtered) and to 3% of the starting P1 plasma
membrane pellet.
In the analytical series, a small amount of frac-
tions 2–4 (Figure 1e) was employed to demonstrate
immunoisolation yield and efficiency. Membrane isol-
ates (Figure 1f, g, h) and supernatants of the binding
reaction (Figure 1f) were analyzed by SDS-PAGE
and showed a major band migrating at approxim-
ately 50 kDa. This was visualized on a Ponceau S
stained nitrocellulose blot and by western blotting
(Figure 1h). Caveolin-1 α and β were the major pro-
teins in addition to the 50 kDa band. For technical
reasons equal quantities of antibodies were resolved
(Figure 1g, h, lanes 2) to allow the comparison of
proteins shown of the unspecific and specific bind-
ing reaction with the antibody preparation only. The
specifically isolated 50 kDa protein migrating be-
neath the IgG heavy chain (Figure 1h) corresponded
to ESA/reggie-1/flotillin-2 [48–50] as analyzed by the
western overlay (Figure 1g). The 42 kDa protein con-
sidered to be ESA/reggie-1/flotillin-2 [48, 49] is of
48 kDa calculated molecular weight in rat [50, 53].
Densitometric quantification of this blot indicated that
ESA/reggie-1/flotillin-2 was 1.4-fold depleted in the
immunoisolate relative to caveolin-1, and suggested
that although it is a major protein, it is also local-
ized to endothelial membrane areas not containing
caveolin-1. Consistently, confocal sections demon-
strated a punctate distribution of caveolin-1 in calf pul-
monary artery, large vessel endothelial (CPAE) cells
(Figure 1i, k) coinciding with ESA/reggie-1/flotillin-
2 positive structures (Figure 1j, l). Caveolin-1 labeled
structures were mostly ESA/reggie-1/flotillin-2 posit-
ive but not vice versa.
Actin in mechanosignaling
The cytoskeleton is implicated in providing mech-
anical stability, tethering and adhesion in mechano-
transduction. We find that actin localized at caveolae
in microvascular SVEC4-10 mouse endothelial cells
as analyzed by confocal immunofluorescence micro-
scopy (Figure 2a-d). Actin distribution was patchy
and bundles were absent in these cells. In contrast,
in CPAE cells (and SVEC4-10 cells; data not shown)
treated with the actin binding drug jasplakinolide [54]
F-actin aggregates containing bundles and formed de
novo, were labeled with caveolin-1 polyclonal an-
tibodies. This was visualized by conventional (Fig-
ure 2e-h) and confocal microscopy (Figure 2g-l).
Actin bundles (Figure 2h, l) were proximal to ca-
veolae and triggered their accumulation (Figure 2g,
k) at or within these cortical areas. Filamin, which
was previously shown to interact with caveolin-1,
may provide a tether of caveolae to the cortical actin
bundles [55]. In contrast to the previous observations
in epithelia [56] the caveolin-1 localization close to
the nucleus here coincided with dense actin structures
(Figure 2j), which with respect to actin seems to be a
specialization of endothelia.
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ATP-driven turnover in complexes of caveolin
We carried out a sucrose gradient velocity sediment-
ation experiment with octylglucopyranoside extracts
of the membrane preparation seen in Figure 1c. The
protein composition was simple with only five major
proteins sedimenting in the 19 S area (Figure 2m).
The presence of caveolin-1 and actin was determ-
ined by western blotting. The majority of caveolin-1
migrated in the 7.4 S area of the sucrose gradient
and overlapped with the actin distribution (Figure 2m,
lanes 4–6). Similar to some previous analyses [57,
58] the extract harbors a large quantity of small
caveolin-1 complexes. But the large, high molecular
weight caveolin-1 complex was originally assumed
to only contain caveolin-1 [59], but this does not
seem to be the case (Figure 2m) and is consistent
with recent findings on heterooligomers of caveolin
and ESA/reggie/flotillin proteins (see below) [60]. De-
tailed inspection of the sedimentation profile after
ATP incubation added during extraction (Figure 2n),
showed that the 7.4 S complex was shifting to a larger
position (lanes 6, 7). Actin sedimented with largely
overlapping profile without ATP (Figure 2m) and was
then dissociated (Figure 2n). This result suggests that
kinases and phosphatases are involved in modulating
caveolin-1 oligomerization and/or interactions, as ex-
pected from differential localization of phosphorylated
and non-phosphorylated forms [57]. We also find
that caveolin-1 preferentially interacts with mono-
meric phosphorylated actin in coimmunoprecipitation
experiments (data not shown).
ATP synthase and annexin V
To allow microsequencing of caveolae components,
we resolved caveolae immunoisolates on 2D-IPG-
SDS-PAGE. To this aim, the residual of the experiment
shown in Figure 1e (fractions 2–4) was used for a
scaled-up immunoisolation reaction. 20 µg of starting
material is shown in panel a (Figure 3) stained with a
highly sensitive silver impregnation protocol, demon-
strating that the composition of the light membrane
fraction was complex and actin was one of the major
components (labeled with an asterik). ESA/reggie-
1/flotillin-2 and caveolin-1 were only detected on
these gels by western blotting since they were smeared
across the entire pI range (data not shown). Resolution
of the immunoisolated material on 2D gels showed
a distinct pattern of proteins of unspecifically bound
(panel b), specifically bound membranes (panel c), and
antibody incubate (panel d). On shrunken gels of the
immunoisolate, a faint silver-stained partial accumu-
lation of caveolin-1 in two spots was visible. Seven
more proteins were not present in panels b and d,
but were discernible in panel c (specifically bound).
These corresponded to factors of 56 kDa, three pro-
teins of approximately 42 kDa, one protein of 36 kDa,
factors of 25 kDa, and 12 kDa apparent molecular
weight. By apparent molecular weight and pI, the
42 kDa proteins could correspond to trimeric G protein
α subunits [11]. Tandem mass spectrometric analysis
yielded five peptides for the 56 kDa protein (1, Fig-
ure 3) corresponding in sequence to rat ATP synthase
β subunit. Five peptide sequences were obtained for
the 36 kDa spot which matched rat annexin V [61]
(2, Figure 3). Calculated molecular weight and pI of
these proteins corresponded to their migration on the
2D gels. Database searches in the rat genome indicated
that the identified peptides of ATP synthase β subunit
and annexin V could be assigned to a unique gene.
Mitochondrial ATP synthase α and β subunits
have previously been shown to be targeted to the en-
dothelial cell surface [35, 40], whereas the α subunit
was present at the hepatic plasma membrane where
this enzyme hydrolyzed ATP [41]. We conclude that
mitochondrial ATP synthase is alternatively targeted
to plasma membrane caveolae and the β subunit is
thus detected in the immunoisolate. Annexin V was
shown to function as an ion channel in liposome pre-
parations [61] but its cellular function has not been
clarified at the mechanistic level and could include
anoikis [62–64]. We conclude that the presence of an-
nexin V may indicate a role of caveolae in calcium
influx.
NADH cytochrome B5 reductase
We set out to analyze the identity of caveolin-1 in-
teracting factors on silver-stained one-dimensional
SDS polyacrylamide gels by tandem mass spectro-
scopy. The preparative immunoprecipitation (Figure 4,
lane 1) was carried out with octylglucopyranoside de-
tergent extract of 12 mg of plasma membrane with
affinity-purified cav1N14 antibodies in a large scale
preparation of rat lung luminal endothelial mem-
brane. Extracts were incubated with cav1N14 affinity-
purified antibodies to retrieve the caveolin-1 α com-
plex (lane 3). Twelve proteins were specifically coim-
munoprecipitated and were not visible in the con-
trol reaction including excess of antigenic peptide
cav1N14 (lane 4) or antibodies only (lane 5). One
protein migrating at 68 kDa was considered to be a
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Figure 2. Caveolin - actin localization in endothelial cells and sedimentation of caveolin complexes. (a)–(d) Confocal microscopy of caveolin-1
and actin in SVEC4-10 cells. The brightest double labeled spots are indicated with ⇒. Cells were grown to confluence on coverslips. Caveolin-1
was visualized with caveolin-1 polyclonal antibodies and secondary fluorescein conjugated antibodies and actin was detected with monoclonal
actin antibodies and secondary Cy3 conjugated antibodies. Two sections at the apical side of cells are shown, distance 0.4 µm. (e)–(h) Localiz-
ation of caveolin-1 and actin in CPA endothelial cells analyzed by immunofluorescence microscopy. Caveolin-1 was visualized with caveolin-1
polyclonal antibodies and secondary fluorescein conjugated antibodies (e, g) and actin was detected with monoclonal actin antibodies and
secondary Cy3 conjugated antibodies (f, h). Cells in (g, h) were treated with 200 nm jasplakinolide for 60 min at 37 ◦C. (i)–(l) Confocal
microscopy of caveolin-1 and actin localization in CPA endothelial cells. Cells were incubated with guanidinium hydrochloride before immun-
ofluorescence treatment. Caveolin-1 was visualized with affinity-purified cav1N14 antibodies and secondary rhodamine conjugated antibodies
(i, k). Actin was detected with monoclonal actin antibodies and secondary fluorescein conjugated antibodies (j, l). Cells shown in (k, l) were
treated with 200 nM jasplakinolide for 60 min at 37 ◦C. Picture sizes: 100 × 100 µm. For visualization of cells in (a-l) exposure times and
photomultiplier settings were chosen to generate no crosstalk between fluorescence channels. Double labeled areas are indicated with ⇒.
(m)–(n) Sedimentation of ocytlglucopyranoside extracts of P1 endothelial plasma membrane. Membranes obtained by silica perfusion from rat
lungs were extracted with octylglucopyranoside in the absence (m) or presence (n) of ATP and centrifuged on 10–35% sucrose gradients. This
experiment was repeated four times with similar results. Fractions were resolved by SDS-PAGE and proteins stained with silver. Molecular
weight markers are indicated. Caveolin-1 and actin were assigned by comparing western blots with the silver-stained gel. Sedimentation size
markers are indicated for both gels in (n).
contamination and was not analyzed by tandem mass
spectroscopy, but later analysis by sucrose velocity
sedimentation suggested that it was not so (Figure 2m,
n). On additional similar gels, further varying quant-
ities of the 68 kDa factor in the different gradient
fractions were seen (unpublished results). The 45 kDa
protein (band 7) corresponded to β/γ actin and was
detected by a precursor ion. Controls by western blot-
ting demonstrated that 5% of total extracted actin was
coprecipitated with caveolin-1 α specifically (data not
shown) suggesting that other comigrating proteolytic
products hindered in gel digestion and/or sequence de-
termination in this experiment with bulk material. The
32 kDa protein (band 10) was identified as the micro-
somal form of NADH cytochrome B5 reductase by a
total of two proteolytic fragments including a peptide
of the microsome-specific N-terminal polypeptide [65,
66]. NADH cytochrome B5 reductase has been iden-
tified as a protein with an N-terminal extension in
microsomes and the bulk of this enzyme was localized
to the endoplasmic reticulum by immunofluorescence
microscopy [65, 66]. Amino acid sequences and sizes
for these factors matched their features indicated in
protein databases. A database search in the rat genome
indicated that the identified peptides of NADH cyto-
chrome B5 reductase could be assigned to a unique
gene.
Quantitative immunoblotting experiments (data
not shown) demonstrated that 6% and 8% of ex-
tract ESA/reggie-1/flotillin-2 and reggie-2/flotillin-1,
respectively, specifically associated with caveolin-1 α
in endothelia, consistent with seminal results obtained
on the interaction of reggie/flotillin proteins with cave-
olin [60]. It is of significance, that the percentage yield
of NADH cytochrome B5 reductase in the coimmuno-
precipitate was large relative to ESA/reggie-1/flotillin-
2 and actin, which were discernible as two major
bands beneath the 52 kDa marker, whereas the re-
ductase appears as a minor protein in the starting
membranes (Figure 4, lane 6). We thus conclude that
the reductase is a protein in the membrane fraction that
selectively partakes in caveolae functions.
Mechanosignaling and transcription
Large amounts of the caveolin-1 protein were previ-
ously found in caveolae, the Golgi apparatus, lipid
bodies and the cytoplasm from several cells, and
in secretory granules from pancreas, but not in the
ER [67–70]. In Clara cells, caveolin is also present
in mitochondria [71]. The scaffolding peptide has am-
phipathic character (amino acids 60–101), interacts
with other proteins and its C-terminal half binds to
membranes [72–75]. To further study the exposure of
this conformationally flexible region of the protein we
raised antibodies reacting with a domain including the
signature motif (PROSITE; amino acids 57–77). Cyto-
plasmic extracts from rat lungs show that caveolin-1 is
consistently present in the cytosol fraction (Figure 5a).
The antibody was specific and selectively reacted with
caveolin-1 α of whole cell extracts of various organs
and cells (Figure 5b). There was little reactivity to-
wards caveolin-1 β but some phosphorylated caveolin-
1 was detected in extracts in which caveolin was
overall abundant consistent with the absence of po-
tentially phosphorylated amino acids in the ‘signature
epitope’. Upon incubation of SVEC4-10 cells with the
affinity-purified antibodies, we detected caveolin-1 as
a brightly labeled protein in the nucleus (Figure 5c, e).
This was analyzed by conventional (panels c, d) and
confocal microscopy (panels e, f) and demonstrated
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Figure 4. Immunoprecipitation of the caveolin-1 complex. P1 membranes were extracted with octylglucopyranoside and incubated with
cav1N14 antibodies (lanes 1, 3). Control experiments included the incubation of extract with cav1N14 antibodies in the presence of cav1N14
antigenic peptide (lane 4) and the incubation of cav1N14 antibodies alone (lane 5). Samples were retrieved with protein A sepharose and
were resolved by SDS-PAGE, molecular weight standards are in lane 2 and are indicated. 20 µg P1 starting material was resolved in lane 6.
Preparative amounts of immunoprecipitate (lane 1) allowed to obtain peptide sequence information from bands 7, 10, 11 and 12 as indicated,
by comparison with the specifically precipitated proteins labeled 1-12 in lane 3. Caveolin-1 α is labeled with an asterik.
that labeling was specific and not present in the pres-
ence of antigenic ‘signature peptide’ (panel d, f) and
was also present in multiple sections of the nucleus
(data not shown). Despite the abundant presence of
caveolin-1 at the plasma membrane in these cells (Fig-
ure 2a, c), caveolae label little with this ‘signature’
antibody. We infer that caveolin-1 changes conforma-
tion and/or that the ‘signature epitope’ of caveolin-1 is
only exposed when the protein is located in the nuc-
leus, and although it is a minor conformer based on
the analysis with other antibodies (Figure 2a, c and
data not shown) it may carry out a biological function.
Figure 3. Caveolae immunoisolation and 2D gel analysis. (a)–(d) 300 µg of caveolae-enriched membranes (derived from pooled fractions 2–4;
Figure 1e) were used for immunoisolation. Membranes were incubated with immunobeads pre-adsorbed without (b, unspecific binding) or with
(c, specific binding) affinity-purified cav1N14 antibodies. 25 µg of starting-material and antibodies alone are shown in (a) and (d) respectively.
They were treated equal to conditions (b) and (c). Samples were resolved on non-linear pH 3.5–10 first dimension IPG strips followed by
9–16% linear SDS-PAGE gels in the second dimension. Gels were stained with silver ammunium nitrate to detect proteins. Specifically bound
proteins are labeled with arrows in (a, c). The specifically enriched 56 kDa protein, No. 1, and the 36 kDa protein, No. 2, were identified as
mitochondrial ATP synthase β chain (1) and annexin V (2) by comparison with a gel from P1 membranes which was used for tandem mass
spectroscopy. The major proteins in (d) correspond to BSA, IgG heavy and light chain (in descending order). Actin is marked with an asterik in
(c) between ‘1’ and ‘2’. Caveolin-1 resolves poorly on 2D gels.
Caveolae regulation
In this work we have begun to analyze the composi-
tion of endothelial caveolae, an organelle implicated
in blood pressure regulation, calcium influx and ion
channel regulation [3, 4, 14, 76–78]. It is essential
that internal osmotic pressure gradients in the cell can
exist that lead to ion fluxes across the plasma mem-
brane [19], and that plasma membrane proton buffers
or dynamics further the local gradient effect [79, 80]
for our model of caveolae function.
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To our surprise, immunoisolated caveolae contain
only two major factors, caveolin-1 and ESA/reggie-
1/flotillin-2, and ATP synthase of mitochondria was
also present. ATP synthase is an ADP converting
enzyme driven by a chemiosmotic potential [81].
Likewise, the plasma membrane form of ATP syn-
thase [35] may harness the membrane potential and
a pH gradient across the plasma membrane for cata-
lysis. It is notable, that the function in ATP synthesis
entails ion channels and/or metabolic differences, and
ESA/reggie-1/flotillin-2 homologues have been im-
plicated in ion channel coactivity [52]. According to
our model, upon local depolarization of the mem-
brane, triggered by mechanosensitive ion channels, a
second messenger, ATP, is generated in the exoplasm
to couple endothelial cells with each other and likely
to the muscle tonus (see also [82]). ATP synthase may
thus integrate effects of pressure stimuli analogous to
metabolic changes in mitochondria. The ion fluxes
triggered by mechanical pressure, short-term, and any
proton fluxes elicited by local conductance, or also by
metabolic pH change, corresponding to a net mem-
brane potential difference of ∼200 mV would result
in ATP generation. The ionic differences as such can
Figure 5. Caveolin-1 localizes to the nucleus in SVEC4-10 cells.
(a) Caveolin-1 is cytosolic. Lung homogenization was carried out
with a teflon pestle homogenizer following perfusion of the vascu-
lature. Standard procedures were used to generate a cytosol prepar-
ation. The nuclear/mitochondrial pellet of a 10’000 g centrifugation
is indicated (lane 1). This pellet includes unlysed cells of the prepar-
ation and corresponds to approximately 40× of the amount of total
protein seen in lanes 2–13 (s and p combined, each). Fractionation
was carried out by further centrifugations at 100’000 g in different
rotors (k factors are indicated). The s (supernatant) fractions lane 2,
4 correspond to cytosol. All sample was recentrifuged at 100’000 g
twice (lanes 6–9 and 10–13) and aliquots were recentrifuged at
100’000 g to separate a supernatant (s) and pellet (p) fraction.
Lanes 10 and 12 correspond to supernatant samples that have been
subjected to three 100’000 g centrifugations in total. Duplicate
samples of lanes 4,5, 8,9, 12,13 were subjected to quick freezing
in liquid nitrogen before further processing. Samples were resolved
by SDS-PAGE and caveolin-1 was detected by western blotting with
caveolin-1 polyclonal antibodies and enhanced chemiluminescence.
Material lighter than 1.04 g/cm3 remains in the supernatant fraction.
(b) Characterization of the caveolin-1 signature antibody. Equal
amounts of cell or organ extract were resolved on 12% SDS-PAGE
and incubated with affinity-purified caveolin-1 signature antibodies.
Caveolin-1 α resolves as the major protein band with little cave-
olin-1 β detected beneath. The phosphorylated form of caveolin-1
is indicated (by comparison). Nitrocellulose blots were developed
by enhanced chemiluminescence. Molecular weight standards are
indicated. (c)–(f) Caveolin-1 localization in SVEC4-10 cells as de-
tected with caveolin-1 ‘signature’ antibodies. Cells were grown on
collagen I coated coverslips. Caveolin-1 was visualized in the nuc-
leus with affinity-purified ‘signature’ antibodies in the absence (c,
e) or presence (d, f) of antigen peptide and detected with secondary
rhodamine conjugated anti-rabbit antibodies. Identical results were
obtained with affinity-purified antibodies of bleads from two dif-
ferent rabbits. Cells were viewed and photographed/scanned with
a Zeiss Axiovert immunofluorescence microscope (c, d) or a Leica
confocal microscope (e, f).
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also be considered an important determinant of local
protein function.
A multitude of factors have previously been iden-
tified in lipid raft preparations, but since they are not
specific with respect to temperature of isolation [83],
nor free of membranes coated with clathrin [84], we
will not discuss them in detail. The subcellular frac-
tionation of lipid raft subdomains has been further ad-
vanced by use of different detergents, but in each case,
the relationship to each other and percentage total in
caveolae has not been determined (see e.g. [85]), and
thus these data do not contribute to further under-
standing with respect to caveolae without subcellular
localization [86].
On the cellular level, endothelia release hyperpol-
arizing factors which act as dilators for the muscle
cell layer. Calcium-dependent potassium channels in
endothelial smooth muscle cells have been implicated
in setting vascular tonus [87] and, strikingly, also
potassium release by endothelial potassium channels
affects the potassium-sensitive potassium channels to
trigger hyperpolarization in muscle [88]. Similar to
synaptic signaling, we suggest that, here, in contrast,
the local generation and release of ATP from en-
dothelia regulates muscle tonus by binding to muscle
P2X receptors [89]. P2X receptors are ionotropic and
may amplify the ATP signal if present in signal con-
ducting endothelial cells [90, 91]. In contrast, P2Y
receptors are heptahelical and of metabotropic type,
couple extracellular ATP and ADP and other nucle-
otides to intracellular signaling by trimeric G proteins,
phospholipase Cβ and calcium signaling, and regu-
late NO production [92]. This idea is consistent with
paracrine signaling in tubuloglomerular regulation of
vascular tone [92–94]. In this vascular bed, adenosine
receptors on muscle play a pivotal role in constric-
tion [94]. The balance of nucleotide supply, ATP
generation by ATP synthase and nucleotide diphos-
phokinase, as well as nucleotide hydrolysis, determine
the concentration of the nucleotide species [92] within
caveolae, inline with a previously proposed function
of caveolae of signaling integration [47, 67]. ATP
synthase at the plasma membrane also hydrolyzes ex-
tracellular ATP, generates a proton gradient with an
endocytic function in hepatic cells and is awaiting fur-
ther mechanistic analyses [41]. The effect of acidosis
on vasoconstriction and mechanosignaling remains to
be analyzed on the molecular level, but intricately de-
pends on the ratio of intracellular and extracellular
pH [95]. A function of ATP in adhesion and the in-
teraction of caveolin-1 with integrins may furthermore
point towards its role in mechanotransduction [27, 96,
97]. A recent study has described the interaction of
adhering cells with their environment, and uncovered
the counterintuitive behaviour that cells escape from
strain in area but grow towards it [98], suggesting that
a multitude of signaling pathways must be involved.
The presence of NADH cytochrome B5 reductase
in caveolae has not been observed and we report
specific interaction of the reductase with caveolin-1
in detergent extracts of rat lung endothelial plasma
membrane as well as faint punctate plasma membrane
localization (data not shown). Faint plasma membrane
localization in addition to the ER location of NADH
cytochrome B5 reductase can also be observed in the
original work [66], but plasma membrane localization
of enzymes and markers is often initially discounted
as a minor fraction if also localized to tubular com-
partments, since for geometrical reasons and lack of
resolution the signal of the entire tubular structure is
increased. Although NADH cytochrome B5 reductase
is a minor component visible on silver-stained gels
in the coimmunoprecipitation, it tightly interacts with
caveolin-1 and its % total yield in the isolate relative
to starting membranes is high compared to coim-
munoprecipitating actin and ESA/reggie-1/flotilllin-2.
Desaturases are coupled to the reductase by the elec-
tron shuttling enzyme cytochrome B5. Cytochrome
B5 is loosely associated [99], and is generally assumed
to transfer electrons derived from NADH to oxy-
gen, to convert C−C bonds to C=C double bonds in
lipid desaturation, but may also have other acceptors.
The reaction is implicated in acyl-CoA desaturation
of various acyl chains, cholesterol and plasmalogen
biosynthesis [100–103].
The fluidity of the membrane bilayer is affected in
mechanosignaling [32], and by lipid desaturation, as
known for many cells in cold adaptation. If lipid gradi-
ents, seemingly implicated in lipid transfer between
two locations, persist long enough, a microenviron-
ment may be generated to regulate mechanotransduc-
tion factors by the enzymatic action of the desaturase
components and by lateral pressure changes, as shown
for prototypical membrane channels in model calcula-
tions [104]. Further supporting is the lipid rigidifying
function of annexin V which may contribute to the
regulation of this process [105]. A general role of ca-
veolin in lipid metabolism, as suggested by analysis of
caveolin-1 knockout mice [106], recent immunoisola-
tion from adipocytes [15], and activated recruitment
to lipid bodies [70] is likely, but in view of a large
fraction of ER and mitochondrial reductase and desat-
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urase enzymes, this quartenary chain may carry out a
specific role in caveolae.
The presence of caveolin-1 in the nucleus of en-
dothelial cells indicates that similar to lipoprotein as-
sembly, which involves apolipoprotein extrusion from
the membrane, caveolin-1 dislocates from the plasma
membrane and likely signals to the nucleus. We expect
that a single explanation for nuclear occurrence of the
protein is not warranted [107]. The details of caveolin
signaling and release, conformational switching and
nuclear import will be subject to future studies.
Materials and methods
Materials
Sucrose (SigmaUltra), HEPES, EDTA, bovine serum
albumin (BSA), ketamine, xylazine, sodium ni-
troprusside, heparin, morpholino ethane sulfonic
acid, NaCl, Nonidet P-40, deoxycholate, sodium
dodecylsulfate, octyl-β-D-glucopyranoside, 1,10-
phenanthroline, PMSF, pepstatin and molecular
weight sedimentation calibration kit MW-GF 1000
were purchased from Sigma. The gradient frac-
tionator was from Labconco. KCl, Tris and β-
mercaptoethanol, DMSO, salicylate, glycerol and
EGTA were bought from Merck, Triton X-100, leu-
peptin and E64 protease inhibitor from Boehringer
Mannheim and Tween-20, PVDF membranes, the
horseradishperoxidase-coupled goat anti-mouse and
anti-rabbit antibodies and the Bradford assay from
BioRad. Colloidal silica Nalco 1060 (average diameter
50 nm) was from Nalco Chemicals, aluminum chloro-
hydroxide from Pfaltz & Bauer and poly(acrylic acid)
(average Mw ∼240’000) from Aldrich. ATP and the
enhanced chemiluminescence (ECL) reagents were
from Boehringer Mannheim. ECL reagents were also
bought from NEN. Ponceau S was from Serva. Cath-
eters 16G/2IN were from Beckton Dickinson and sur-
gical suture 45 cm/2-0 silk/CE-6/24 mm from Amer-
ican Cyanamid. Nycodenz was from Gibco BRL.
The homogenizer (S-type) was from Braun. Protran
BA85 nitrocellulose was purchased from Schleicher
& Schuell. The caveolin-1 monoclonal antibodies
C43420, C13620 and polyclonal antibody C13630, the
ESA E35820 and flotillin F65020 monoclonal anti-
bodies and control lysates of different cells and brain
were from Transduction Laboratories. The caveolin-1
monoclonal antibody Cl. Z034 was from Zymed and
Cl. 2283 from ICN. The β-actin AC15 monoclonal
antibody was from Sigma. The Cy3 and fluorescein
conjugated goat anti-mouse and goat anti-rabbit anti-
bodies were from Jackson Immuno Research Labor-
atories and Cappel, respectively. The rhodamine and
fluorescein conjugated goat anti-mouse and -rabbit
antibodies were from ICN. Jasplakinolide was from
Molecular Probes. ProteinA-sepharose was from Phar-
macia. Express S35-Met/Cys protein label was from
ICN. Dynabeads M280 were bought from Dynal.
Sepharose Cl-4B beads were from Pharmacia. The
rat caveolin-1 α N-terminal peptide (cav1N14; amino
acid residues 1-14-Cys) was synthesized by the Micro-
chemistry Core Facility of the Rockefeller Research
Laboratories, Sloan Kettering-Institute. The peptide
57-77-Cys of rat caveolin-1 α (signature peptide) was
from Neosystems. Reagents for 2D gel analysis were
from the following sources: 2,7 naphtalene disulfonic
acid was from Acros, acetic acid, ammonia, citric
acid, dithiothreitol, ethanol, formaldehyde, glycerol,
hydrochloric acid, methanol, paraffine oil, sodium
acetate, Tris base and urea from Merck, acrylogel-
piperazine diacrylyl 2.6 solution and Resolytes pH 4–8
from BDH, agarose from Eurogentec, Coomassie bril-
liant blue R-250, ammonium persulfate and sodium
dodecylsulfate from Bio-Rad, bromophenol blue, glut-
araldehyde, glycine, butan-2-ol, silver nitrate and
sodium thiosulfate from Fluka, cholamidopropanes-
ulfate, iodoacetamide and thiourea from Sigma, IPG
NL pH 3.5–10 strips from Pharmacia-Hoeffer and
TEMED from Serva. CPA endothelial cells (batch F-
13887) and SVEC4-10 cells (batch 204826) were from
the American Type Culture Collection (ATCC). Me-
dia for tissue culture (as indicated by ATCC), fetal
bovine serum, Trypsin-EDTA, penicillin/streptomycin
and Glutamax were from Gibco/BRL. Trypsin was
from Promega. Collagen (rat tail type I) was purchased
from Collaborative Biomedical Products.
Methods
Database search
Database searches were carried out with the Rat BLAT
Search, Jan. 03 assembly (http://genome.ucsc.edu).
Caveolin-1 antibody production
The rat cav1N14 and rat caveolin-1 α 57–77 ‘sig-
nature’ peptides were coupled to keyhole limpet
hemocyanin via C-terminal cysteines, antibodies were
raised in rabbits (three and two, respectively) with
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Freund’s adjuvant. For affinity-purification peptide-
coupled Sepharose Cl-4B beads were used according
to standard procedures. The antisera (cav1N14) were
screened by immunoprecipitation of caveolin-1 from
P1 membrane 1% TritonX-100, 0.05 Tween-20 (in
PBS) extracts warmed to 37 ◦C for 5 min during ex-
traction followed by incubation at 4 ◦C, centrifugation
and addition to the immunobeads. These were in-
cubated and processed as described below. Efficiency
of caveolin-1 immunoprecipitation was quantified by
western blotting with caveolin-1 polyclonal antibody
(C 13630). Antibody incubations were in PBS, 5%
fat-free milk and 0.2% Tween-20.
Membrane isolation from rat lungs
Coating of colloidal silica and rat lung perfusion was
carried out according to Jacobson et al., [108]; anim-
als were anaesthetized before the experiment. Protease
inhibitor mix consisted of 1 mM 1,10-phenanthroline,
1 mM PMSF and a cocktail of 2 µg/ml E64,
10 µg/ml leupeptin, 10 µg/ml pepstatin (1000× stock
in DMSO) (PIC) and was added to the homogenates.
A P1 and P2 silica pellicle fraction was obtained by
one or two centrifugations, respectively, through a
nycodenz cushion as described.
Electron microscopy
The P1 fraction was fixed in 2.5% glutaraldehyde in
PIPES buffer (20 mM), postfixed in 2% OsO4 (in
H2O) for one hour and dehydrated in a graded series
of EtOH. Samples were embedded in Polybed 812
(Polysciences) and sectioned (60 nm) with a Reichert
Ultracut S ultramicrotom. Samples were poststained
with 5% uranylacetate, 0.4% lead citrate in MeOH and
viewed and photographed with JEOL 1200 Ex electron
microscope.
Immunoisolation of caveolae from rat lungs
Immunoisolation was carried out according to Stan
et al. with minor modifications [9]. The P1 fraction
(12 mg) was sonicated for 4 × 20 sec in a buffer con-
taining 2 M KCl and 31 mM HEPES pH 7.4, PIC and
1.25 mM PMSF/phenanthroline. Sonication was inter-
mittent with cooling in-between on ice. Samples were
adjusted to 1.7 M sucrose, 10 mM HEPES pH 7.4,
2 mM EDTA, 630 mM KCl final concentration and
loaded into a TST41.14 centrifuge tube, overlaid with
4 ml 1.09 M sucrose in 500 mM KCl, 10 mM HEPES
pH 7.4 and a 1 ml cushion of 0.25 M sucrose in
500 mM KCl, 10 mM HEPES pH 7.4. The samples
were centrifuged for 13 h, 40’000 rpm at 4 ◦C in
the ultracentrifuge. Fractions were collected from the
gradient with a gradient maker and a small quantity
was resolved by SDS-PAGE. The remainder (340 µg)
was used for immunoisolation. Membranes were di-
luted fourfold with 0.1% BSA, 2 mM EDTA in PBS
(IB) and PIC was added before isolation. All tubes
for immunoisolation (2 ml, Eppendorf) were preincub-
ated with IB for 30 min before addition of reagents.
For the analytical experiment (Figure 1f) 50 µl Dyna-
beads M280 coated with sheep anti rabbit IgG were
pre-incubated with IB and then with or without 12 µg
caveolin-1 N1-14 (cav1N14) affinity-purified antibod-
ies overnight at 4 ◦C, excess antibodies were removed
by an IB wash. Sample membranes (2 × 23 µg) were
added to the tubes for overnight incubation with gentle
shaking at 4 ◦C. Samples were washed with four loads
of ice cold IB by retrieval with a magnet, once with
PBS and loaded onto the gel. For large scale isolation
the amount of beads and antibodies were doubled for
each reaction tube and 10 tubes in total were used,
5 for the control reaction in the absence of antibod-
ies and 5 for the specific retrieval with 150 µg protein
each, BSA was increased to 2 mg/ml for the overnight
incubation in the membrane addition step. Samples
and controls were treated identically, this included
the incubation of Dynabeads without antibodies or in-
cubation of cav1N14-coated Dynabeads without mem-
branes except that the ‘antibody only’ incubation was
carried out in 2 tubes overnight following the pre-
coating with cav1N14 antibody. The precoating was
carried out with the total amount of Dynabeads in
one tube in all experiments to avoid slight experi-
mental variations and pipetting errors. The residual of
the pooled fractions 2–4 (2 × 20 µg) of the original
gradient was diluted three-fold with PBS and spun at
100’000 rpm, 4 ◦C in a TLA100.2 rotor (Beckman)
to pellet membranes and for gel loading (for silver-
stain and western blotting). Protein amounts were
determined with the Bradford assay. Samples were
solubilized in 350 µl 2D sample loading buffer includ-
ing a trace of bromophenol blue for 25 min at 37 ◦C,
1’500 rpm in a Thermomixer (Eppendorf). Samples
were spun for 10 min at room temperature in the Ep-
pendorf centrifuge at 14’000 rpm and supernatants
were used for the 2D gel analysis. The polyacrylamide
gels were stained with silver to visualize the resolved
proteins [109]. This silver stain was used in all analyt-
ical methods. For the experiment shown in Figure 1g,
h we employed Eupergit C1Z beads for the immun-
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oisolation. The immunoisolation buffer was the same
(IB) except that BSA was adjusted to 2 mg/ml. C1Z
beads (a kind gift of Eric Dumermuth, Basel and An-
nette Hille-Rehfeld, Göttingen) were coupled to sheep
anti rabbit Fc fragments as described [110]. 6 µg of
affinity-purified cav1N14 antibodies were added to the
caveolae-enriched membrane fraction (diluted 1:3 in
IB) and incubated overnight at 4 ◦C with gentle shak-
ing (for one tube and reaction). Membranes for this
immunoisolation were obtained from a P1 membrane
fraction as described above except that intermittent
sonication was carried out 2 × 30 sec on ice and
the use of a SW60 rotor for membrane fractiona-
tion in the sucrose density gradient. Here cushions
were identical, samples were centrifuged for 210 min,
50’000 rpm at 4 ◦C and the 0.25 M / 1.09 M sucrose
interface was collected by fractionation with a gradi-
ent maker. Amounts were too small to determine and
are visible on the Ponceau S stained nitrocellulose
blot. 60 µl of a 1:1 suspension of coupled Eupergit
C1Z beads were preincubated with IB for 1 hour at
4 ◦C and then added to the membranes. The incuba-
tion was continued for 3 hours and followed by four
washes in IB and one wash in PBS. Centrifugation
of Eupergit beads was carried out for 5 min in an
Eppendorf centrifuge at 2’500 rpm at 4 ◦C for pel-
leting during washes. For western blotting of these
samples the reggie-1 monoclonal antibody was used at
a concentration of 0.5 µg/ml. Caveolin-1 was detected
with the mixture of C43420, C13620, Cl. Z034, Cl.
2283 caveolin-1 monoclonal antibodies (0.05 µg/ml,
0.25 µg/ml, 0.05 µg/ml, 0.2 µg/ml concentration) by
western overlay.
2D IPG-SDS-PAGE and western blotting
IPG strips pH 3.5–10 (18 cm) were loaded for
12 hours during rehydration. Loading buffer was as
described [111]. The machine (Pharmacia) was pro-
grammed in voltage steps of 500 V 1h, 1000 V 1h,
2000 V 30 min, 4000 V 30 min, 8000 V to 90 kVh
total and 500 V holding voltage. The voltage ramped
to 5’500 V maximum. The procedure included slight
modifications from the method previously described.
Strips were equilibrated with 3 ml of 50 mM Tris
pH 6.8, 6 M urea, 30% v/v glycerol, 2% SDS, 2%
dithiothreitol followed by incubation in 3 ml 50 mM
Tris pH 6.8, 6 M urea, 30% glycerol (v/v), 2.5%
iodoacetamide and a trace of bromophenol blue for
5 min. Second dimensions (BioRad) were run as
9–16% gradient gels with acrylamide/piperazine diac-
rylyl as crosslinker (9–16% T, 2.6% C). The gels
contained 1.25 mg/ml thiosulfate. Second dimensions
(without a stacking gel) were overlaid with a solu-
tion of 0.5% w/v agarose in 25 mM Tris pH 8.3,
190 mM glycine, 0.05% SDS and 0.8 mM EDTA.
They were run at constant voltage 50 mA/gel, 8 ◦C for
approximately 5.5 hours until the dye front reached
the bottom of the plate. For control blots on PVDF
membranes a Towbin-buffer of 25 mM Tris, 190 mM
glycine with 0.05% SDS, without methanol, was used.
Preparative gels were run the same and stained with
Coomassie brilliant blue R-250. Silver staining of ana-
lytical samples on 2D gels was done as published with
an ammoniacanial silver nitrate solution and the fol-
lowing modifications of adding 0.05% 2,7-naphtalene-
disulfonic acid to the washes after sensitization in
2.5% glutaraldehyde with 0.5 M sodium acetate in
water (pers. comm. H. Leffers). Gels were incubated
with a solution of 25% ethanol, 2% PEG-4000 and
dried on a standard gel dryer or left in the same solu-
tion. Some gels stored in sealed plastic bags inadvert-
ently dried as well. Western blotting was carried out
with caveolin-1 antibodies with a mixture of C43420,
C13620, Cl. Z034, Cl. 2283 caveolin-1 monoclonal
antibodies (concentrations 0.05 µg/ml, 0.25 µg/ml,
0.05 µg/ml, 0.2 µg/ml) or caveolin-1 polyclonal an-
tibody (at 50 ng/ml). Gels were compared to standard
gels on the Expasy-Server (http://www.expasy.ch).
Velocity sedimentation
200 µg of P1 membranes were extracted in 300 µl
final volume of 40 mM octyl-β-D-glucopyranoside in
TNE buffer (25 mM Tris-HCl pH 7.5, 100 mM NaCl,
2 mM EGTA, 1 mM MgCl2, 2% β-mercaptoethanol,
PIC) for 5 min at 37 ◦C in an Eppendorf 5436
shaker (1’000 rpm) and then for 30 min at 4 ◦C
on a rotary shaker. 2 mM ATP was added where
indicated to the extraction mix and sucrose gradi-
ent solutions. The silica particles were pelleted by
centrifugation 10 sec, 4 ◦C, 14’000 rpm in an Ep-
pendorf centrifuge. Supernatants were added on top
of a 10–35% (wt/vol) sucrose gradient. The lin-
ear gradient was poured with the density gradi-
ent maker/fractionator with TNE solution containing
40 mM octyl-β-D-glucopyranoside, no PIC. Consist-
ency was controlled by refractometry. Centrifugation
was for 22 h, 30’000 rpm, SW60 Ti rotor and 12 ◦C.
400 µl fractions were collected from the top of the
gradient with the density gradient fractionator. Frac-
tions were acetone precipitated. Samples were separ-
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ated by 12% SDS-PAGE after boiling in SDS-PAGE
sample buffer. Sedimentation coefficients of protein
complexes were estimated by comparison with stand-
ard proteins centrifuged in the same experiment: car-
bonic anhydrase (29 kDa), BSA (66 kDa, 4.3 S),
alcohol dehydrogenase (150 kDa, 7.4 S), β-amylase
(200 kDa, 9 S), apoferritin (443 kDa), and thyro-
globulin (669 kDa, 19 S). S values were taken from
published data.
Caveolin immunoprecipitation
15 mg of the silica pellicle P1 endothelial lu-
minal plasma membranes were extracted for 90 min
in IP buffer. IP buffer was 40 mM octyl-β-D-
glucopyranoside, 1 mM EDTA, 0.5 mM PMSF,
0.5 mM 1,10-phenanthroline, 1 mM DTT in PBS con-
taining PIC. The material was centrifuged for 10 min
at 14’000 rpm in the Eppendorf centrifuge; the su-
pernatant was brought to 1 mg/ml BSA final concen-
tration. The extract was precleared for 60 min with
500 µl protein A-Sepharose (1:1 in IP buffer, preb-
locked with 5 mg/ml BSA for 1 h and washed 3× be-
fore use). These beads were discarded. For lane 1
(Figure 4) caveolin-1 was immunoprecipitated from
12 mg corresponding extract with cav1N14 affinity-
purified antibodies, for the analytical lanes 3-5 1.5 mg
each was used with equal amounts of antibodies with
or without excess (8’000-fold, molar) of cav1N14 pep-
tide (preincubated with the antibody). As a further
control excess of antibody (150 µg) was loaded onto
the same gel (not shown) to allow comparison with
possibly abundant affinity-purified antibody contam-
inants. Incubation of extracts was overnight, 4 ◦C.
Antigen-antibody complexes were collected by pro-
tein A-Sepharose retrieval (preblocked with IP buffer
containing 5 mg/ml BSA 1 h at 4 ◦C). Incubation was
for 1 h at 4 ◦C, followed by 2 washes with IP buffer
(with 1 mg/ml BSA) and 2 washes with PBS. Samples
were separated by 12% SDS-PAGE after boiling in
Laemmli SDS-PAGE sample buffer. Gels were stained
with a modified, aqueous silver staining protocol.
Microsequencing
Microsequencing was carried out by electron spray
ionization mass spectral analysis (ESI-MS). 2D gels
were run with 1.4 mg of P1 and P2 membranes
from rat lung luminal endothelial plasma membrane
and gel spots were combined after Coomassie blue
staining and computational comparison with the im-
munoisolate and starting membranes (Figure 3). The
electrophoretic programming and conditions of the
2D gel run were identical. From one dimensional gels,
samples were excised following staining of the gels
with silver as described previously. Gel pieces were
excised and washed five times with 30 µl each of 40%
n-propanol, followed by five washes with 30 µl each
of 200 mM NH4HCO3 containing 50% acetonitrile
and dried in a speed vac concentrator. For digestion,
0.5 µg trypsin in 10 µl 100 mM NH4HCO3 was ad-
ded to allow reswelling of the gel pieces. Enough
100 mM NH4HCO3 was added to completely immerse
the gel pieces in the liquid. Digestion was at 37 ◦C for
two hours. The supernatant was collected and the gel
pieces were extracted twice with 15 µl each of 0.1%
formic acid followed by extraction twice by 15 µl
acetonitrile. All supernatants were pooled and dried
in a speed vac rotator. For mass spectral analysis, the
peptides were redissolved in 10 µl 0.1% trifluoro-
acetic acid and 5 µl were injected onto a capillary
column (100 µm i.d.) packed with POROS R2 ma-
terial. The peptides were eluted with a linear gradient
of 0.02% acetic acid to methanol containing 0.02%
acetic acid in 15 min at a flow rate of approximately
200 nl/min. Eluting peptides were introduced into the
mass spectrometer via a microelectrospray ion source.
Mass spectral data were acquired on a TSQ7000 triple
quadrupole instrument (Finnigan, San José, CA) with
data controlled switching between precursor ions and
daughter ions during a single chromatographic run.
For precursor ion scanning, the resolution of the in-
strument was set to 1 Dalton. For operation in the
MS/MS mode, the resolution of Q1 was set to trans-
mit a window of 4 Dalton and the resolution of Q3
was adjusted to 1.5 Dalton. Daughter ion scanning
was performed between 50 to 2’000 Dalton in 3.5 s.
Argon was used as the collision gas at a pressure
of 3.0 mTorr. The collision energy was kept con-
stant at −32 eV during individual experiments. The
daughter ion spectra acquired were used to identify
the proteins with the SEQUEST program [112] and
Mascot search software. For actin and reggie/flotillin
quantitation in the coprecipitate 500 µg correspond-
ing P1 membrane extract was used and solublized in
500 µl of the same solutions as described above (ca-
veolin immunoprecipitation). Treatment was identical.
Specifically coprecipitating proteins were analyzed by
peptide competition, 100 µg corresponding P1 mem-
brane extract was used for a concentration series for
western blotting in parallel to allow comparison and
to determine the linearity of the antibody response.
Actin was detected with the AC15 monoclonal anti-
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body, ESA/reggie-1/flotillin-2 and reggie-2/flotillin-1
with ESA and flotillin antibodies, respectively, fol-
lowed by secondary HRP-coupled mouse antibodies.
ECL exposures were quantified by densitometry.
Cytosol preparation
Rat lung cytosol was prepared by standard perfu-
sion [108] with Dulbecco’s MEM with sodium nitro-
prusside for 2 min at r.t. followed by 4 min at 8 ◦C
and 6 min with cytosol buffer (25 mM Tris pH 7.4,
500 mM KCl, 1 mM DTT, 250 mM sucrose, 2 mM
MgCl2, 5 mM EGTA and PMSF, 1,10-phenathroline,
PIC. Tissue was processed as described for P1 pellicle
preparation, that is homogenization with a Dounce
(S-type, 20 strokes) and filtration. Filtrate was con-
trolled in the microscope for cell lysis and appearance
of nuclei. The sample was spun sequentially for 1 h,
10’000 rpm, TST60, for 1 h 30’000 rpm, TST60, for
1 h, 30’000 rpm, TST60 all at 4 ◦C. Supernatants of
each run were recentrifuged for 1 h, 50’000 rpm, TLA
100. Duplicates on the gel are derived from control
samples, which were frozen before recentrifugation.
K factors were estimated based on H2O, particles
lighter than 1.04 g/cm3 did not pellet.
Immunofluorescence microscopy
Cells were grown on coverslips coated with a solu-
tion of 5 µg/ml collagen I (with PBS/acetic acid).
Immunofluorescence was carried out as previously
described [113]. Briefly, coverslips were fixed in
4% paraformaldehyde in PBS for 20 min and incub-
ated for 10 min with 50 mM ammonium chloride.
The cells were permeabilized with 0.1% Triton X-
100 for 4 min and incubated for 10 min with 6 M
guanidinium-HCl in 50 mM Tris-HCl pH 7.5 where
indicated [114]. Following two washes in PBS the
samples were blocked in 5% FCS (heat inactivated)
in PBS (IFB). All incubations were carried out at r.t.
The affinity-purified cav1N14, ‘signature’ caveolin-1,
the ESA and actin antibody were used at a concentra-
tion of 33 µg/ml, 20 µg/ml, 25 µg/ml and 12.5 µg/ml
(IgG1 or total affinity-purified protein), respectively,
in IFB. The caveolin-1 polyclonal antibody C13630
was used at a dilution of 1:100 in IFP. Antibodies
are defined by these names (see figure legends). The
secondary rhodamine and fluorescein conjugated goat
anti-rabbit and-mouse antibodies were diluted 1:200
in IFB for the double labeling of caveolin-1 and actin.
The secondary fluorescein and Cy3 conjugated goat
anti-rabbit and -mouse antibodies were diluted 1:300
and 1:400, respectively, in IFB for the double labeling
of caveolin-1 and ESA (flotillin-2). Single labeling
was always carried out with identical dilutions and
samples. Photomultiplier amplification was firstly ad-
justed to control samples incubated in the absence of
primary antibodies and, secondly, to single labeled
controls to avoid cross talk between channels. Cells
were viewed and photographed with an Axiophot
(Zeiss) microscope with a video camera or a Leica
NT confocal microscope using oil immersion object-
ives. Confocal sections are as indicated. Pinhole size
was 0.16 for the ‘signature’ antibody, 0.25 for the actin
antibody and 0.4 for the ESA antibody experiments.
In the jasplakinolide experiments cells were treated
with 200 nM jasplakinolide for 60 min at 37 ◦C in
MEM. Jasplakinolide was diluted from a 1′000× stock
solution in DMSO.
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